Quantcast
Home » News
Home » News

FDA: Little evidence to support testosterone drugs

Published September 3, 2014 11:05 am

Pharmaceuticals • But agency is unconvinced by studies suggesting there are serious risks.
This is an archived article that was published on sltrib.com in 2014, and information in the article may be outdated. It is provided only for personal research purposes and may not be reprinted.

Washington • The Food and Drug Administration says there is little evidence that testosterone-boosting drugs taken by millions of American men are beneficial, though the agency is also unconvinced by recent studies suggesting the hormone carries serious risks.

The agency posted its review online ahead of a public meeting later this month to discuss the benefits and risks of treatments that increase the male hormone. Regulators agreed to convene the Sept. 17 meeting after two federally funded studies found links between testosterone therapy and heart problems in men.

The scrutiny comes amid a marketing blitz for new pills, patches and formulations that has transformed testosterone into a multibillion-dollar market.



Advertisements for prescription gels like Fortesta and Androgel promise men relief from common signs of aging, including low libido, fatigue and weight gain.

 

 

 

USER COMMENTS
Reader comments on sltrib.com are the opinions of the writer, not The Salt Lake Tribune. We will delete comments containing obscenities, personal attacks and inappropriate or offensive remarks. Flagrant or repeat violators will be banned. If you see an objectionable comment, please alert us by clicking the arrow on the upper right side of the comment and selecting "Flag comment as inappropriate". If you've recently registered with Disqus or aren't seeing your comments immediately, you may need to verify your email address. To do so, visit disqus.com/account.
See more about comments here.
comments powered by Disqus